BioSpace News Archive

a vial with a syringe stuck in its stopper in black and white on a pink background with a yellow circle

Vaccines

JPM26: Sanofi’s CEO Keen To Buy the Dip as Vaccine Rhetoric Impacts Short-Term Sales

Buying vaccine biotech Dynavax was an easy choice for Sanofi despite antivaccine moves by the Trump administration.

January 14, 2026

·

3 min read

·

Annalee Armstrong

AbbVie's office in South San Francisco, California

Cancer

JPM26: AbbVie Seeks Respect for Oncology Pipeline Following RemeGen Buy

Primarily known as an immunology and neuroscience company, AbbVie wanted to put the biopharma world on notice during its J.P. Morgan presentation: its oncology portfolio is underappreciated. This week, the Illinois-based company dove into the sizzling PD-1/VEGF space with a licensing deal with China-based RemeGen.

January 14, 2026

·

2 min read

·

Heather McKenzie

Press Releases

Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects

January 14, 2026

·

6 min read

Press Releases

NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2